These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2465446)

  • 1. Pharmacological actions of DPN 205-734, a novel cardiotonic agent.
    Salzmann R; Scholtysik G; Markstein R; Bormann G
    J Cardiovasc Pharmacol; 1988 Oct; 12(4):451-60. PubMed ID: 2465446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological actions of APP 201-533, a novel cardiotonic agent.
    Salzmann R; Bormann G; Herzig JW; Markstein R; Scholtysik G
    J Cardiovasc Pharmacol; 1985; 7(3):588-96. PubMed ID: 2410694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular actions of DPI 201-106, a novel cardiotonic agent.
    Salzmann R; Scholtysik G; Clark B; Berthold R
    J Cardiovasc Pharmacol; 1986; 8(5):1035-43. PubMed ID: 2429077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.
    Shahid M; Martorana MG; Cottney JE; Marshall RJ
    Br J Pharmacol; 1990 Aug; 100(4):735-42. PubMed ID: 2169938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive inotropic and electrophysiological effects of APP 201-533 can be explained by an increase of cardiac cyclic AMP.
    Scholtysik G; Honerjäger P; Markstein R; Bormann G
    J Cardiovasc Pharmacol; 1985; 7(3):597-603. PubMed ID: 2410695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of MS-857, a new and potent cardiotonic agent, in isolated mammalian cardiac muscles.
    Kamiya J; Maruyama M; Kawai K; Kobari T
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):790-7. PubMed ID: 2481195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of stereoselectivity in the inotropic and phosphodiesterase inhibitory effects of saterinone enantiomers.
    Armah BI; Muster D; Raap A; Brückner R; Graziadei I
    Arzneimittelforschung; 1989 Nov; 39(11):1384-92. PubMed ID: 2559738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.
    Heber D; Heers C; Ravens U
    Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive inotropic and vasodilatory actions of saterinone in vivo.
    Armah BI; Hofferber E; Jacobitz P
    Arzneimittelforschung; 1988 Sep; 38(9):1303-9. PubMed ID: 2906247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties.
    Scholtysik G; Salzmann R; Berthold R; Herzig JW; Quast U; Markstein R
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):316-25. PubMed ID: 2991779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.
    Lues I; Beier N; Jonas R; Klockow M; Haeusler G
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotonic activity of 5-methyl-6-(4-pyridyl)-2H-1,4-thiazin-3(4H)-one hydrochloride (ZSY-27).
    Yoshioka K; Hino M; Yoshimura A; Yamazaki H; Takase M; Ono H
    J Pharmacobiodyn; 1988 Nov; 11(11):715-21. PubMed ID: 3236203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action.
    Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y
    Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polypeptide (AP-A) from sea anemone (Anthopleura xanthogrammica) with potent positive inotropic action.
    Shibata S; Norton TR; Izumi T; Matsuo T; Katsuki S
    J Pharmacol Exp Ther; 1976 Nov; 199(2):298-309. PubMed ID: 10426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of positive inotropic activity of Ro 13-6438, a structurally novel cardiotonic agent with vasodilating properties.
    Holck M; Thorens S; Muggli R; Eigenmann R
    J Cardiovasc Pharmacol; 1984; 6(3):520-30. PubMed ID: 6202981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological actions of SDZ 218-135, a novel positive inotropic agent.
    Zierhut W; Salzmann R; Bormann G; Rüegg UT; Hof RP
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):235-44. PubMed ID: 7918136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.